Bio-Techne (TECH) Competitors $58.78 +0.31 (+0.53%) Closing price 07/25/2025 04:00 PM EasternExtended Trading$58.96 +0.18 (+0.31%) As of 07/25/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock TECH vs. BRKR, A, CRL, DHR, IQV, MTD, RVTY, TMO, WAT, and ILMNShould you be buying Bio-Techne stock or one of its competitors? The main competitors of Bio-Techne include Bruker (BRKR), Agilent Technologies (A), Charles River Laboratories International (CRL), Danaher (DHR), IQVIA (IQV), Mettler-Toledo International (MTD), Revvity (RVTY), Thermo Fisher Scientific (TMO), Waters (WAT), and Illumina (ILMN). Bio-Techne vs. Its Competitors Bruker Agilent Technologies Charles River Laboratories International Danaher IQVIA Mettler-Toledo International Revvity Thermo Fisher Scientific Waters Illumina Bruker (NASDAQ:BRKR) and Bio-Techne (NASDAQ:TECH) are both mid-cap life sciences tools & services companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, valuation, institutional ownership, analyst recommendations, earnings, profitability, media sentiment and dividends. Do analysts rate BRKR or TECH? Bruker presently has a consensus target price of $52.89, suggesting a potential upside of 26.11%. Bio-Techne has a consensus target price of $69.58, suggesting a potential upside of 18.38%. Given Bruker's higher possible upside, analysts clearly believe Bruker is more favorable than Bio-Techne.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bruker 0 Sell rating(s) 6 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.40Bio-Techne 0 Sell rating(s) 6 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 2.62 Does the media refer more to BRKR or TECH? In the previous week, Bruker had 14 more articles in the media than Bio-Techne. MarketBeat recorded 28 mentions for Bruker and 14 mentions for Bio-Techne. Bio-Techne's average media sentiment score of 0.90 beat Bruker's score of 0.38 indicating that Bio-Techne is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Bruker 8 Very Positive mention(s) 4 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 2 Very Negative mention(s) Neutral Bio-Techne 5 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders & institutionals believe in BRKR or TECH? 79.5% of Bruker shares are held by institutional investors. Comparatively, 99.0% of Bio-Techne shares are held by institutional investors. 27.3% of Bruker shares are held by company insiders. Comparatively, 3.9% of Bio-Techne shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Which has better earnings and valuation, BRKR or TECH? Bio-Techne has lower revenue, but higher earnings than Bruker. Bio-Techne is trading at a lower price-to-earnings ratio than Bruker, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBruker$3.37B1.89$113.10M$0.5280.65Bio-Techne$1.16B7.95$168.10M$0.8271.68 Which has more risk and volatility, BRKR or TECH? Bruker has a beta of 1.18, suggesting that its share price is 18% more volatile than the S&P 500. Comparatively, Bio-Techne has a beta of 1.39, suggesting that its share price is 39% more volatile than the S&P 500. Is BRKR or TECH a better dividend stock? Bruker pays an annual dividend of $0.20 per share and has a dividend yield of 0.5%. Bio-Techne pays an annual dividend of $0.32 per share and has a dividend yield of 0.5%. Bruker pays out 38.5% of its earnings in the form of a dividend. Bio-Techne pays out 39.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Is BRKR or TECH more profitable? Bio-Techne has a net margin of 10.89% compared to Bruker's net margin of 2.31%. Bruker's return on equity of 19.47% beat Bio-Techne's return on equity.Company Net Margins Return on Equity Return on Assets Bruker2.31% 19.47% 5.95% Bio-Techne 10.89%13.17%10.17% SummaryBio-Techne beats Bruker on 12 of the 19 factors compared between the two stocks. Get Bio-Techne News Delivered to You Automatically Sign up to receive the latest news and ratings for TECH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TECH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TECH vs. The Competition Export to ExcelMetricBio-TechneMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$9.17B$3.06B$5.69B$9.50BDividend Yield0.55%2.37%4.58%4.01%P/E Ratio71.6821.1828.1020.05Price / Sales7.95288.50432.4490.07Price / Cash25.2742.7636.2258.56Price / Book4.488.378.665.87Net Income$168.10M-$55.19M$3.25B$258.55M7 Day Performance13.00%5.88%4.23%3.74%1 Month Performance11.33%17.33%10.52%11.75%1 Year Performance-27.07%4.42%34.41%18.03% Bio-Techne Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TECHBio-Techne4.6739 of 5 stars$58.78+0.5%$69.58+18.4%-25.3%$9.17B$1.16B71.683,100Analyst UpgradeBRKRBruker4.9669 of 5 stars$35.63-12.1%$52.89+48.4%-34.7%$5.40B$3.37B68.5211,396High Trading VolumeAAgilent Technologies4.8688 of 5 stars$112.12-1.6%$139.77+24.7%-11.0%$31.85B$6.51B27.6817,900Positive NewsCRLCharles River Laboratories International4.4603 of 5 stars$149.70-3.1%$174.54+16.6%-20.3%$7.35B$4.05B-230.3120,100Positive NewsDHRDanaher4.8289 of 5 stars$188.23-1.0%$248.48+32.0%-23.9%$134.71B$23.88B36.5563,000Trending NewsEarnings ReportAnalyst ForecastAnalyst RevisionIQVIQVIA4.5674 of 5 stars$159.06-1.0%$222.45+39.9%-14.3%$27.52B$15.41B21.6788,000Trending NewsEarnings ReportAnalyst ForecastInsider TradeAnalyst RevisionMTDMettler-Toledo International4.1453 of 5 stars$1,168.60-2.2%$1,280.90+9.6%-10.4%$24.28B$3.87B29.1417,300Positive NewsUpcoming EarningsRVTYRevvity2.9445 of 5 stars$90.90-2.5%$123.07+35.4%-8.0%$10.71B$2.76B38.6811,000News CoverageUpcoming EarningsDividend AnnouncementAnalyst UpgradeTMOThermo Fisher Scientific4.954 of 5 stars$405.15-2.3%$599.30+47.9%-19.5%$152.94B$42.88B23.76125,000Trending NewsEarnings ReportAnalyst ForecastAnalyst RevisionWATWaters4.7942 of 5 stars$282.01-1.9%$381.94+35.4%-2.5%$16.78B$2.96B25.597,600Trending NewsAnalyst DowngradeHigh Trading VolumeILMNIllumina4.6269 of 5 stars$94.79-1.4%$125.11+32.0%-6.8%$15.01B$4.37B-15.629,030Upcoming Earnings Related Companies and Tools Related Companies BRKR Competitors A Competitors CRL Competitors DHR Competitors IQV Competitors MTD Competitors RVTY Competitors TMO Competitors WAT Competitors ILMN Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TECH) was last updated on 7/26/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump's 2025 Economic Revolution Is Here Are Your Retirement Savings Ready?Time is short. Trump's reforms may be coming fast—and the financial system roller coaster may be a ride that y...Create New Advertiser | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…GoldCo Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bio-Techne Corp Please log in to your account or sign up in order to add this asset to your watchlist. Share Bio-Techne With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TECH Stock Alerts